Product Images Amjevita

View Photos of Packaging, Labels & Appearance

Figure 1 - amjevita 01
Figure 2 - amjevita 02
Image - amjevita 03
Image - amjevita 04
Image - amjevita 05
Image - amjevita 06
Image - amjevita 07
Image - amjevita 08
Image - amjevita 09
Image - amjevita 10
Image - amjevita 11
Image - amjevita 12
Image - amjevita 13
Image - amjevita 14
Image - amjevita 15
Image - amjevita 16
Image - amjevita 17
Image - amjevita 18
Image - amjevita 19
Image - amjevita 20
Image - amjevita 21
Image - amjevita 22
Image - amjevita 23
Image - amjevita 24
Image - amjevita 25
Image - amjevita 26
Image - amjevita 27
Image - amjevita 28
Image - amjevita 29
Image - amjevita 30
Image - amjevita 31
Image - amjevita 32
Image - amjevita 33
Image - amjevita 34
Image - amjevita 35
Image - amjevita 36
Image - amjevita 37
Image - amjevita 38
Image - amjevita 39
PRINCIPAL DISPLAY PANEL - 20 mg Syringe Carton - amjevita 40
PRINCIPAL DISPLAY PANEL - 40 mg Syringe Carton - amjevita 41
PRINCIPAL DISPLAY PANEL - 40 mg Autoinjector Carton - amjevita 42

Product Label Images

The following 42 images provide visual information about the product associated with Amjevita NDC 55513-480 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - amjevita 01

The text appears to be a graph showing the administration of a medication (40mg every other week) compared to a placebo over a period of weeks. The label on the x-axis indicates the measurement of time.*

Figure 2 - amjevita 02

The text is describing a chart or graph showing the ASAS 20 response of a placebo group (consisting of 107 participants) compared to an adalimumab group (consisting of 208 participants) over a period of 24 weeks. The chart/plot shows time on the x-axis (measured in weeks) and the ASAS 20 response on the y-axis. Without access to the visual aids, further interpretation or insight is not feasible.*

Image - amjevita 03

Image - amjevita 04

This appears to be a set of instructions or information related to a medical injection device. It includes details about the expiration date and the color-coding of various components, such as the yellow window and safety guard. It also references removing the yellow cap.*

Image - amjevita 05

Image - amjevita 06

Image - amjevita 07

This text is describing two body parts: the stomach area (abdomen) and the thigh.*

Image - amjevita 08

Image - amjevita 09

Image - amjevita 10

Image - amjevita 11

Image - amjevita 12

Image - amjevita 13

Image - amjevita 14

Image - amjevita 15

Image - amjevita 16

Image - amjevita 17

Image - amjevita 18

Image - amjevita 19

Image - amjevita 20

Image - amjevita 21

This appears to be a list of body parts: Stomach area (abdomen) and Thigh. No further context or description is available.*

Image - amjevita 22

Image - amjevita 23

Image - amjevita 24

Image - amjevita 25

Image - amjevita 26

Image - amjevita 27

This text seems to be a list of components of a medication syringe including a plunger rod, finger flange, label with an expiration date, syringe barrel, medicine, and a needle cap.*

Image - amjevita 28

This appears to be a list of various components typically found in medical syringe equipment, including a used plunger rod, finger flange, label and expiration date, used syringe barrel, used needle, and needle cap. It does not provide any specific information about the condition of these items or their intended use.*

Image - amjevita 29

Image - amjevita 30

Image - amjevita 31

Not available.*

Image - amjevita 32

Image - amjevita 33

This is a medical term indicating two parts of the human body. The first one refers to the area of the body located between the chest and the pelvis, commonly known as the "stomach" or "abdomen". This area contains vital organs such as the stomach, liver, intestines, kidneys, and spleen. The second term refers to the upper part of the leg, extending from the hip to the knee, known as the "thigh". It contains several muscles, including the quadriceps and hamstrings, that are essential for movement and mobility.*

Image - amjevita 34

Image - amjevita 35

Image - amjevita 36

Image - amjevita 37

Image - amjevita 38

Image - amjevita 39

PRINCIPAL DISPLAY PANEL - 20 mg Syringe Carton - amjevita 40

This is a medication called Adalimumab-atto, which is an injectable solution for subcutaneous use. It comes in a single-dose prefilled syringe with a storage temperature between 2-8°C (36°F-46°F) and should not be frozen or shaken. It is intended for people who weigh between 18kg to <%0 kg and the package includes additional instructions for storage. However, the text provided is unreliable and contains errors that make the information difficult to read.*

PRINCIPAL DISPLAY PANEL - 40 mg Syringe Carton - amjevita 41

PRINCIPAL DISPLAY PANEL - 40 mg Autoinjector Carton - amjevita 42

This appears to be a description of a medication called "fAMJEVITA" with the active ingredient "adalimumab-atto". It is a sterile solution in a prefilled autoinjector that should be stored refrigerated and protected from light, and should not be shaken or frozen. It is intended for subcutaneous use only and the enclosed medication guide is required for each use. The product is not made with natural rubber latex and should not be re-used. Other text in the description is not readable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents